Showing 1 - 18 results of 18 for search 'Harrison W. Farber', query time: 0.06s
Refine Results
-
1
Management of hospitalized patients with pulmonary arterial hypertension and COVID-19 infection by Sandeep Sahay, Harrison W. Farber
Published 2020-06-01
Article -
2
Under pressure: pulmonary hypertension associated with left heart disease by Harrison W. Farber, Simon Gibbs
Published 2015-12-01
Article -
3
-
4
The PH‐ILD Detection tool: External validation and use in patients with ILD by Raj Parikh, David M. O'Sullivan, Harrison W. Farber
Published 2023-07-01
Article -
5
-
6
Stress Cardiomyopathy Precipitated by Withdrawal of Epoprostenol by William J. Gionfriddo, MD, Hanna N. Ahmed, MD, Harrison W. Farber, MD
Published 2020-02-01
Article -
7
Epoprostenol‐associated ascites in pulmonary arterial hypertension by Noah C. Schoenberg, Nicole F. Ruopp, Raj D. Parikh, Harrison W. Farber
Published 2022-04-01
Article -
8
-
9
Severe pulmonary hypertension–interstitial lung disease presenting as right ventricular failure: stabilisation with intravenous prostacyclin and maintenance with inhaled prostacycl... by Raj Parikh, Alysse Thomas, Aldo Sharofi, Niala Moallem, Garrett Fiscus, Harrison W. Farber
Published 2024-01-01
Article -
10
-
11
Clinical trial design in phase 2 and 3 trials for pulmonary hypertension by Sylvia Nikkho, Peter Fernandes, R. James White, Chunqin (CQ) Deng, Harrison W. Farber, Paul A Corris
Published 2020-11-01
Article -
12
-
13
Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States by Harrison W. Farber, Hayley D. Germack, Nicole S. Croteau, Jason C. Simeone, Fei Tang, Carly J. Paoli, Gurinderpal Doad, Sumeet Panjabi, Teresa De Marco
Published 2024-04-01
Article -
14
Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis by Lisa M. Rice, Julio C. Mantero, Eric A. Stratton, Rod Warburton, Kari Roberts, Nicholas Hill, Robert W. Simms, Robyn Domsic, Harrison W. Farber, Robert Lafyatis
Published 2022-05-01
Article -
15
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis by Lisa M. Rice, Julio C. Mantero, Eric A. Stratton, Rod Warburton, Kari Roberts, Nicholas Hill, Robert W. Simms, Robyn Domsic, Harrison W. Farber, Robert Layfatis
Published 2018-08-01
Article -
16
Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real‐world patient data repository by Harrison W. Farber, Murali M. Chakinala, Michelle Cho, Robert P. Frantz, Andrew Frick, Lisa Lancaster, Scott Milligan, Ronald Oudiz, Sumeet Panjabi, Yuen Tsang, Steven D. Nathan
Published 2023-07-01
Article -
17
Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension by Olivier Sitbon, Sylvia Nikkho, Raymond Benza, Chunqin (CQ) Deng, Harrison W. Farber, Mardi Gomberg-Maitland, Paul Hassoun, Christian Meier, Joanna Pepke-Zaba, Krishna Prasad, Werner Seeger, Paul A Corris
Published 2020-11-01
Article -
18
United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications by C. Gregory Elliott, Eric D. Austin, David Badesch, Jessica Badlam, Raymond L. Benza, Wendy K. Chung, Harrison W. Farber, Kathy Feldkircher, Adaani E. Frost, Abby D. Poms, Katie A. Lutz, Michael W. Pauciulo, Chang Yu, William C. Nichols
Published 2019-05-01
Article